Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › octreotide

octreotide

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of octreotide

15 trials tracked of octreotide: 8 in phase 3 or 4 and 1 with published results. The most-cited published study has 5 citations.

15Trials tracked
8Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 3 Phase 3 5 Phase 2 6 Phase 1 1
  1. Phase 4 A Study to Evaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus Lanreotide Completed · 5 cited
  2. Phase 4 Comparison of Terlipressin, Somatostatin, and Octreotide for Control of Variceal Bleeding Completed
  3. Phase 4 Effect of Octreotide on the Colonic Motility in Pediatric Patients Completed
  4. Phase 3 Octreotide in Treating Patients With Cancer-Related Malignant Ascites Completed
  5. Phase 3 Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor Completed
  6. Phase 3 Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly Completed
Show 9 more trials
  1. Phase 3 Efficacy and Safety of Pasireotide Long Acting Release vs. Octreotide Long Acting Release in Patients With Metastatic Carcinoid Disease Completed
  2. Phase 3 Octreotide in Severe Polycystic Liver Disease Completed
  3. Phase 2 AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors Completed
  4. Phase 2 Treatment With Octreotide in Patients With Lymphangioleiomyomatosis Completed
  5. Phase 2 Single Dose Pharmacology Study of DG3173 and Octreotide in Acromegalic Patients. Completed
  6. Phase 2 The Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated Acromegalics Completed
  7. Phase 2 Octreotide for Management of Bronchorrhea in Mechanically Ventilated Patients Completed
  8. Phase 2 Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Completed
  9. Phase 1 Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults Completed

Showing the 15 most-cited and recently-updated of 15 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
MDT management of insulinoma in pregnancy yields partial glycaemic control but fetal growth restriction occurred in this case
Diabetes & Endocrinology Sys. Review
MDT management of insulinoma in pregnancy yields partial glycaemic control but fetal growth restriction occurred in this case Multidisciplinary care manages insulinoma in pregnancy with mixed fetal outcomes
This literature review presents a case report of a 36-year-old gravida 4 para 2 woman with insulinoma during pregnancy. The multidisciplinar…
A single case report shows partial blood sugar control with octreotide and fetal growth restriction after EUS-RFA for an insulinoma during p…
Frontiers Jun 4, 2026
Axitinib + Octreotide Shows PFS Benefit in Extrapancreatic NETs per Central Review (HR 0.71)
Oncology RCT
Axitinib + Octreotide Shows PFS Benefit in Extrapancreatic NETs per Central Review (HR 0.71) Can a blood vessel blocker help slow rare gut tumors? Study shows mixed results for new combination treatment
In the AXINET phase II/III trial, axitinib plus octreotide LAR significantly improved median PFS per blinded independent central review (16.…
A new blood vessel blocker combined with standard hormone shots helped rare gut tumors shrink and delayed growth longer than placebo, despit…
Mar 30, 2026